Maillard reaction and immunogenicity of protein therapeutics

doi:10.5411/wji.v6.i1.19

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (14543)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-9) series.

Item

Count

PDF

1192

WORD

448

HTML

10088

Figures (1-9)

326

Sum=12054

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1078

Download

1411

Sum=2489

Mar 27, 2016 (publication date) through Nov 27, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Immunology

ISSN

2219-2824

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Immunol. Mar 27, 2016; 6(1): 19-38
Published online Mar 27, 2016. doi: 10.5411/wji.v6.i1.19

Full Size Figure Download Figure

Figure 9 Proposed immune responses against advanced glycation end products modified IFNβ (IFNβ-advanced glycation endproducts). AGEs: Advanced glycation endproducts.

Citation: Tsekovska R, Sredovska-Bozhinov A, Niwa T, Ivanov I, Mironova R. Maillard reaction and immunogenicity of protein therapeutics. World J Immunol 2016; 6(1): 19-38
URL: https://www.wjgnet.com/2219-2824/full/v6/i1/19.htm
DOI: https://dx.doi.org/10.5411/wji.v6.i1.19